Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Could This Be Novartis' Next Blockbuster Medicine?
Could This Be Novartis' Next Blockbuster Medicine?
Could This Be Novartis' Next Blockbuster Medicine?
Submitted by
admin
on January 27, 2023 - 10:27am
Source:
Motley Fool
News Tags:
Novartis
iptacopan
PNH
Headline:
Could This Be Novartis' Next Blockbuster Medicine?
snippet:
Iptacopan aims to treat patients with a life-threatening blood disease.
If approved, the indication could top $1 billion in sales for the drugmaker.
The stock is trading at a discounted valuation compared to its peers.
Do Not Allow Advertisers to Use My Personal information